Can a transgender person be an occupational diver? Demonstration from a case report.

This is the first case report about a transgender professional diver. The purpose of this article is to show the professional adaptations to help him to continue occupational dive and to raise the question of the impact on diving risks of hormonal treatment in this case. He was a 39-year-old man when he began his transition. He had worked as a diver for 9 years before his transition. When he changed to look like a woman, there were a few difficulties in continuing his professional activity. The main difficulty was that he looked like a woman while working with men. Modesty was a crucial issue in the enterprise. There were other problems such as the organisation of premises, the physical workload and the interaction between treatments and diving. There is a lack of a law to guide the employer. French legislation does not address the issue of transsexuals for this profession. The medical recommendations do not specify contraindications or adaptations for diving safely. Because of his transition, he lost muscle mass. The occupational physician helped to adjust his activity: decreasing the weight of his diving suit, creating a female-like locker room etc. Finally, the question of the risk of decompression illness arose. Legal hormonal medication seems not to significantly increase the risk of decompression illness, but this diver was taking illicit treatment to speed up the transition. The occupational physician recommended taking the legal hormonal medication.

[1]  Mohannad A. Awad,et al.  Postoperative Complications following Primary Penile Inversion Vaginoplasty among 330 Male‐to‐Female Transgender Patients , 2017, The Journal of urology.

[2]  F. Marvel,et al.  Cardiovascular Disease Among Transgender Adults Receiving Hormone Therapy , 2017, Annals of Internal Medicine.

[3]  D. Buteau,et al.  Updates in Decompression Illness. , 2017, Emergency medicine clinics of North America.

[4]  R. Quinton,et al.  Transgender hormone therapy: understanding international variation in practice. , 2017, The lancet. Diabetes & endocrinology.

[5]  Naveen Dhawan,et al.  Breast Cancer Suspicion in a Transgender Male-to-Female Patient on Hormone Replacement Therapy Presenting with Right Breast Mass: Breast Cancer Risk Assessment and Presentation of a Rare Lesion , 2017, Case reports in oncological medicine.

[6]  M. Bélanger,et al.  Genital Sensory Detection Thresholds and Patient Satisfaction With Vaginoplasty in Male-to-Female Transgender Women. , 2017, The journal of sexual medicine.

[7]  T. Deloughery,et al.  Thrombotic issues in transgender medicine: A review , 2017, American journal of hematology.

[8]  Costantino Balestra,et al.  Venous gas emboli are involved in post-dive macro, but not microvascular dysfunction , 2017, European Journal of Applied Physiology.

[9]  C. Sedlak,et al.  Transgender Individuals and Osteoporosis Prevention. , 2017, Orthopedic nursing.

[10]  K. Ward,et al.  Cancer in Transgender People: Evidence and Methodological Considerations. , 2017, Epidemiologic reviews.

[11]  J. Potter,et al.  Affirmative and Responsible Health Care for People with Nonconforming Gender Identities and Expressions. , 2016, AMA journal of ethics.

[12]  S. Reisner,et al.  What's in a Guideline? Developing Collaborative and Sound Research Designs that Substantiate Best Practice Recommendations for Transgender Health Care. , 2016, AMA journal of ethics.

[13]  R. Hayon Gender and Sexual Health: Care of Transgender Patients. , 2016, FP essentials.

[14]  B. Loddé,et al.  Recommandations de bonne pratique pour le suivi en santé au travail des travailleurs exposés aux contraintes hyperbares , 2016 .

[15]  Kelika A. Konda,et al.  Peru's HIV care continuum among men who have sex with men and transgender women: opportunities to optimize treatment and prevention , 2016, International journal of STD & AIDS.

[16]  S. Reisner,et al.  Advancing methods for US transgender health research , 2016, Current opinion in endocrinology, diabetes, and obesity.

[17]  E. Van Caenegem,et al.  Bone in trans persons. , 2015, Current opinion in endocrinology, diabetes, and obesity.

[18]  J. Dewitte,et al.  Predicted nine-year risk of diabetes among professional divers: a prospective study. , 2015, International maritime health.

[19]  B. Mendonca,et al.  Clinical management of transsexual subjects. , 2014, Arquivos brasileiros de endocrinologia e metabologia.

[20]  O. Lalude Risk of Cardiovascular Events with Hormonal Contraception: Insights from the Danish Cohort Study , 2013, Current Cardiology Reports.

[21]  P. Molinier,et al.  Travail et santé mentale : approches cliniques , 2012 .

[22]  J. Dewitte,et al.  Cardiovascular risk factors and cardiovascular risk assessment in professional divers. , 2012, International maritime health.

[23]  Simon J Mitchell,et al.  Decompression illness , 2011, The Lancet.

[24]  A. Boussuges,et al.  Gender differences in circulating bubble production after SCUBA diving , 2009, Clinical physiology and functional imaging.

[25]  F R Rosendaal,et al.  The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study , 2009, BMJ : British Medical Journal.

[26]  Inyoung Kim,et al.  Effects of breath-hold diving on bone mineral density of women divers. , 2006, Joint, bone, spine : revue du rhumatisme.

[27]  U. Wisløff,et al.  Nos inhibition increases bubble formation and reduces survival in sedentary but not exercised rats , 2003, The Journal of physiology.

[28]  Avner Bar-Hen,et al.  Ascent rate, age, maximal oxygen uptake, adiposity, and circulating venous bubbles after diving. , 2002, Journal of applied physiology.

[29]  T. J. Robinson Decompression sickness in women divers. , 1988, Undersea biomedical research.